In COPD and tuberculosis comorbidity, NF-κB activation is enhanced due to the synergistic effect of chronic inflammation induced by inhalation stimuli in COPD and mycobacterial persistence in tuberculosis. This evidence concerns the gene NFKB1 and tuberculosis.